267 related articles for article (PubMed ID: 29959199)
21. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical profiling of Wnt, NF-kappaB, Stat3 and Notch signaling in human epidermal tumors.
Liu ZL; Li Y; Kong QY; Zhan C; Wang Q; Chen XY; Sun Y; Wen S; Tu CX; Liu J; Li H
J Dermatol Sci; 2008 Nov; 52(2):133-6. PubMed ID: 18703315
[No Abstract] [Full Text] [Related]
23. Baicalin Antagonizes Prostate Cancer Stemness via Inhibiting Notch1/NF-κB Signaling Pathway.
Wu MH; Wu K; Zhu YB; Li DC; Yang H; Zeng H
Chin J Integr Med; 2023 Oct; 29(10):914-923. PubMed ID: 37357241
[TBL] [Abstract][Full Text] [Related]
24. GASC1 promotes glioma progression by enhancing NOTCH1 signaling.
Xiao Z; Yang X; Liu Z; Shao Z; Song C; Zhang K; Wang X; Li Z
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649841
[TBL] [Abstract][Full Text] [Related]
25. Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+ endometrial cancer cells.
Shang C; Lang B; Meng LR
Cancer Biol Ther; 2018 Feb; 19(2):113-119. PubMed ID: 27791463
[TBL] [Abstract][Full Text] [Related]
26. Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma.
Su C; Chen Z; Luo H; Su Y; Liu W; Cai L; Wang T; Lei Y; Zhong B
J Exp Clin Cancer Res; 2011 Sep; 30(1):85. PubMed ID: 21939555
[TBL] [Abstract][Full Text] [Related]
27. Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer.
Yuan Z; Liang X; Zhan Y; Wang Z; Xu J; Qiu Y; Wang J; Cao Y; Le VM; Ly HT; Xu J; Li W; Yin P; Xu K
Br J Cancer; 2020 Apr; 122(9):1342-1353. PubMed ID: 32203206
[TBL] [Abstract][Full Text] [Related]
28. Identification of Human Cutaneous Squamous Cell Carcinoma Cancer Stem Cells.
Olivero C; Morgan H; Patel GK
Methods Mol Biol; 2019; 1879():415-433. PubMed ID: 29582375
[TBL] [Abstract][Full Text] [Related]
29. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer.
Upadhyay P; Nair S; Kaur E; Aich J; Dani P; Sethunath V; Gardi N; Chandrani P; Godbole M; Sonawane K; Prasad R; Kannan S; Agarwal B; Kane S; Gupta S; Dutt S; Dutt A
Oncotarget; 2016 Aug; 7(31):50437-50449. PubMed ID: 27391340
[TBL] [Abstract][Full Text] [Related]
30. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.
Vilimas T; Mascarenhas J; Palomero T; Mandal M; Buonamici S; Meng F; Thompson B; Spaulding C; Macaroun S; Alegre ML; Kee BL; Ferrando A; Miele L; Aifantis I
Nat Med; 2007 Jan; 13(1):70-7. PubMed ID: 17173050
[TBL] [Abstract][Full Text] [Related]
31. NFκB-Mediated Invasiveness in CD133
Nomura A; Gupta VK; Dauer P; Sharma NS; Dudeja V; Merchant N; Saluja AK; Banerjee S
Mol Cancer Res; 2018 Jan; 16(1):162-172. PubMed ID: 28970361
[TBL] [Abstract][Full Text] [Related]
32. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
Hong KJ; Wu DC; Cheng KH; Chen LT; Hung WC
J Cell Physiol; 2014 Feb; 229(2):191-201. PubMed ID: 23881612
[TBL] [Abstract][Full Text] [Related]
33. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
Xu WW; Li B; Zhao JF; Yang JG; Li JQ; Tsao SW; He QY; Cheung ALM
Cancer Lett; 2018 Jul; 425():88-100. PubMed ID: 29604392
[TBL] [Abstract][Full Text] [Related]
34. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
[TBL] [Abstract][Full Text] [Related]
35. Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-κB/MDR1 pathway in colorectal cancer.
Zhan Y; Qiu Y; Wang H; Wang Z; Xu J; Fan G; Xu J; Li W; Cao Y; Le VM; Ly HT; Yuan Z; Xu K; Yin P
Cancer Sci; 2020 May; 111(5):1619-1630. PubMed ID: 32058643
[TBL] [Abstract][Full Text] [Related]
36. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
37. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
[TBL] [Abstract][Full Text] [Related]
38. A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line.
de Maria S; Santoro A; Fuggetta MP; Rocchetti R; Cottarelli A; Lanzilli G; Stiuso P; Angelico G; Spadola S; Franco Zannoni G; Rubini C; Emanuelli M; Carmela Pedicillo M; Pannone G; Muzio LL
APMIS; 2020 Dec; 128(12):637-646. PubMed ID: 32911563
[TBL] [Abstract][Full Text] [Related]
39. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
40. S100A4 suppresses cancer stem cell proliferation via interaction with the IKK/NF-κB signaling pathway.
Zhu Y; Zhou Y; Zhou X; Guo Y; Huang D; Zhang J; Wang C; Cai L
BMC Cancer; 2018 Jul; 18(1):763. PubMed ID: 30045697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]